Ovarian Cancer Treatment May Be Found In Epigenetic Therapy

January 15, 2018 Tim Barry

Ovarian cancer is not the most common of cancers, but it is the leading cause of gynecological cancer related death for women in the U.S. It is often hard to detect; many women don’t display symptoms until it’s in an advanced stage, and then it may be too late for treatment as it can easily spread to the uterus, cervix, or fallopian tubes. Treatments typically include chemotherapy, radiation, hormone therapy, or clinical trials for up-and-coming medicines; however, the new field [more…]

Epigenetics Holds the Answer to Chemoresistance in Ovarian Cancer Patients

May 14, 2014 Bailey Kirkpatrick

A study conducted at Georgia State University and the University of Georgia gives us novel insight into the chemoresistance of ovarian cancer and offers a potential therapeutic approach to overcoming it. Inhibiting enzymes that lead to changes in gene expression could decrease chemotherapy resistance in ovarian cancer patients, researchers say. Dr. Susanna Greer and her colleagues have identified two enzymes that suppress proteins that regulate cell survival and chemoresistance in ovarian cancer. Ovarian cancer is the deadliest of all gynecologic [more…]

WIE-logo-icon

If you like reading our articles…

Join our e-newsletter! Stay up-to-date with our weekly posts on epigenetics and health, nutrition, exercise, and more.